Clinical Trial Update: Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing weekly paclitaxel and carboplatin versus the standard paclitaxel and carboplatin regimen in stage IIIB or IV non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED